Time-dependent Treatment Effects of Prostate-specific Membrane Antigen Radioligand Therapy in Metastatic Castration-resistant Prostate Cancer in the ENZA-p (ANZUP1901) Trial

European Urology Focus · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles